Delivery Order 36E79726D0010-15B50326F00000059
- Not listed
- The Federal Correctional Institution Big Spring awarded a delivery order to Seqirus USA Inc. for staff influenza vaccine supplies for the 2026-2027 season. This firm fixed-price delivery order, valued at $2,333.20, was issued on March 13, 2026, with a completion date of April 30, 2026. The order is being fulfilled from Seqirus's facility in Summit, New Jersey, with no set-aside designation applied. This delivery order represents a routine procurement to support annual flu vaccination...
- Seqirus USA Inc. was awarded a $3,102 firm-fixed-price delivery order by the Federal Correctional Institution Williamsburg for influenza virus vaccine for the 2025-2026 season. The award was made on September 18, 2025, with an ultimate completion date of September 30, 2025, and does not utilize a set-aside designation. The place of performance is Summit, New Jersey, where Seqirus maintains its primary operations as a leading supplier of seasonal flu vaccines to federal agencies. This delivery...
- Seqirus USA Inc., a biotechnology company headquartered in Summit, New Jersey, was awarded a delivery order by the Federal Prison Camp Alderson (a civilian facility under the Bureau of Prisons) for inmate flu vaccine services in the second quarter of fiscal year 2026. The contract, valued at $2,541.60, is a firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of September 30, 2026. Performance will take place in Alderson, West Virginia. This delivery...
- Seqirus USA Inc. was awarded a firm fixed price delivery order by the Department of Justice Bureau of Prisons Federal Correctional Institution Greenville to supply inmate influenza vaccines. The $7,610.06 contract has a completion date of February 20, 2024 and was awarded on March 30, 2021 without a set-aside designation. As the prime contractor, Seqirus USA Inc. will deliver influenza virus vaccines to support immunization programs for federal inmates and correctional facility staff at the...
- Seqirus USA Inc. was awarded a $22,529.50 firm fixed price delivery order against the Department of Justice Bureau of Prisons' indefinite-delivery/indefinite-quantity contract vehicle to provide influenza vaccines for the Federal Medical Center in Carswell, Texas. The delivery order has a period of performance through October 15, 2021 and was awarded on April 7, 2021 without any set-aside designation. Seqirus will deliver the flu vaccines to the Summit, New Jersey location for distribution to...
- This is a firm-fixed-price delivery order contract awarded by the Federal Correctional Complex Butner, part of the U.S. Department of Justice, to Seqirus USA Inc. for the supply of influenza virus vaccines for inmates during the 2025-2026 season. The contract has a ceiling value of $17,836.50 and a completion date of September 30, 2025. Seqirus USA Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods, will provide a range of influenza vaccine formulations to support the...
- Seqirus USA Inc. was awarded a $745 firm fixed price delivery order against the Department of Justice Bureau of Prisons influenza virus vaccine contract vehicle. The contract calls for Seqirus to provide 2022-2023 reference influenza virus vaccine to United States Penitentiary Lewisburg in Summit, New Jersey by September 30, 2022. No set-aside designation was applied to this award to supply influenza vaccines in support of the Bureau of Prisons' public health programs. Seqirus will perform as...
- The Department of Justice Bureau of Prisons awarded a $15,186.75 firm-fixed-price delivery order contract to Seqirus USA Inc., a global biotechnology company, for the delivery of inmate population influenza virus vaccines for the 2025-2026 period. The contract does not have a set-aside designation. Seqirus USA Inc. is a foreign-owned, for-profit manufacturer of goods, registered in the SAM.gov system, and has been a federal contractor since 2008, providing influenza vaccines to various...
- This is a firm-fixed-price delivery order contract awarded by the Federal Correctional Complex Allenwood, part of the U.S. Department of Justice, to Seqirus USA Inc. for the supply of influenza vaccines. The contract has a ceiling value of $10,105.56 and a period of performance ending on October 15, 2025. Seqirus USA Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products, has been awarded this contract to provide influenza vaccine formulations, including quadrivalent vaccines,...
- This is a firm-fixed-price delivery order contract awarded by the Federal Correctional Institution Berlin, a civilian agency, to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company. The contract is for the delivery of influenza vaccines to inmates and staff at the facility, with a ceiling value of $2,714.25 and a completion date of October 15, 2025. Seqirus USA Inc. is a global leader in the development, manufacturing, and delivery of influenza vaccines, and has been awarded...
- 36E79726D0010Indefinite Delivery Contract
- 36E79726D0010-15B50326F00000059Delivery Order
Seqirus USA Inc. has been awarded a delivery order by the Federal Correctional Institution Big Spring, a civilian facility under the Department of Justice, to supply influenza vaccines for the 2026-2027 season. The contract is a firm fixed-price delivery order with a ceiling value of $6,999.60 and an ultimate completion date of April 30, 2026. The vaccine will be delivered to the contractor's headquarters location in Summit, New Jersey. This award carries no set-aside designation, reflecting the company's competitive standing in the federal marketplace for vaccine procurement. This delivery order is issued under one of Seqirus's larger indefinite delivery contract vehicles, consistent with the company's extensive history supplying influenza vaccines to the Bureau of Prisons across multiple correctional facilities nationwide. Seqirus USA Inc., headquartered in Summit, New Jersey, is a foreign-owned biotechnology company and registered federal contractor since 2008 specializing in influenza vaccine development and manufacturing. The company serves as a critical supplier across federal agencies including the Department of Veterans Affairs, Indian Health Service, Defense Logistics Agency, and Centers for Disease Control and Prevention, with contract values ranging substantially based on population requirements and facility needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 3/15/26 |